345 related articles for article (PubMed ID: 34102461)
1. National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness.
Han BH; Doran KM; Krawczyk N
J Subst Abuse Treat; 2022 Jan; 132():108504. PubMed ID: 34102461
[TBL] [Abstract][Full Text] [Related]
2. Opioid use disorder treatment for people experiencing homelessness: A scoping review.
McLaughlin MF; Li R; Carrero ND; Bain PA; Chatterjee A
Drug Alcohol Depend; 2021 Jul; 224():108717. PubMed ID: 33985863
[TBL] [Abstract][Full Text] [Related]
3. Homelessness and publicly funded substance use disorder treatment in California, 2016-2019: Analysis of treatment needs, level of care placement, and outcomes.
Padwa H; Bass B; Urada D
J Subst Abuse Treat; 2022 Jun; 137():108711. PubMed ID: 35012791
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the U.S.
Curran L; Manuel J
Int J Drug Policy; 2024 Apr; 126():104342. PubMed ID: 38479161
[TBL] [Abstract][Full Text] [Related]
5. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
[TBL] [Abstract][Full Text] [Related]
6. Impact of Medicaid expansion on inclusion of medications for opioid use disorder in homeless adults' treatment plans.
Swartz N; Odayappan S; Chatterjee A; Cutler D
J Subst Use Addict Treat; 2023 Sep; 152():209059. PubMed ID: 37207834
[TBL] [Abstract][Full Text] [Related]
7. Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.
Hartung DM; Markwardt S; Johnston K; Geddes J; Baker R; Leichtling G; Hildebran C; Chan B; Cook RR; McCarty D; Ghitza U; Korthuis PT
Addict Sci Clin Pract; 2022 Aug; 17(1):45. PubMed ID: 35986384
[TBL] [Abstract][Full Text] [Related]
8. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
JAMA Psychiatry; 2023 May; 80(5):508-514. PubMed ID: 36988913
[TBL] [Abstract][Full Text] [Related]
9. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
[TBL] [Abstract][Full Text] [Related]
10. Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder.
Ford BR; Bart G; Grahan B; Shearer RD; Winkelman TNA
J Addict Med; 2021 Apr; 15(2):159-162. PubMed ID: 32868682
[TBL] [Abstract][Full Text] [Related]
11. A National Study of Homelessness, Social Determinants of Health, and Treatment Engagement Among Outpatient Medication for Opioid Use Disorder-Seeking Individuals in the United States.
Gaeta Gazzola M; Carmichael ID; Christian NJ; Zheng X; Madden LM; Barry DT
Subst Abus; 2023; 44(1):62-72. PubMed ID: 37226909
[TBL] [Abstract][Full Text] [Related]
12. Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults.
Welsh JW; Dennis ML; Funk R; Mataczynski MJ; Godley MD
J Subst Abuse Treat; 2022 Jan; 132():108584. PubMed ID: 34391589
[TBL] [Abstract][Full Text] [Related]
13. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.
Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J
J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615
[TBL] [Abstract][Full Text] [Related]
14. Differential adoption of opioid agonist treatments in detoxification and outpatient settings.
Dunn KE; Huhn AS; Strain EC
J Subst Abuse Treat; 2019 Dec; 107():24-28. PubMed ID: 31757261
[TBL] [Abstract][Full Text] [Related]
15. Hospital admissions for physical health and psychosocial adversity among people experiencing homelessness in England: a population-based retrospective cross-sectional study.
Luchenski S; Aldridge R; Stevenson F; Tariq S; Hewett N; Hayward A
Lancet; 2023 Nov; 402 Suppl 1():S10. PubMed ID: 37997049
[TBL] [Abstract][Full Text] [Related]
16. Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019".
Krawczyk N; Rivera BD; Jent V; Keyes KM; Jones CM; Cerdá M
Int J Drug Policy; 2022 Dec; 110():103786. PubMed ID: 35934583
[TBL] [Abstract][Full Text] [Related]
17. Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States.
Short VL; Hand DJ; MacAfee L; Abatemarco DJ; Terplan M
J Subst Abuse Treat; 2018 Jun; 89():67-74. PubMed ID: 29706175
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal cross-sectional analysis of substance use treatment trends for individuals experiencing homelessness, criminal justice involvement, both, or neither - United States, 2006-2018.
Shearer RD; Shippee ND; Vickery KD; Stevens MA; Winkelman TNA
Lancet Reg Health Am; 2022 Mar; 7():. PubMed ID: 35382494
[TBL] [Abstract][Full Text] [Related]
19. Correlates of death during outpatient treatment for opioid use disorder: A national study.
Goldman JE; Samuels EA; Rich JD; Marshall BDL
J Subst Abuse Treat; 2020 May; 112():76-85. PubMed ID: 32199549
[TBL] [Abstract][Full Text] [Related]
20. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
